• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Financial incentives plus information decrease patient preference for diagnostic testing

Bioengineer by Bioengineer
October 28, 2019
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: KIRSTY CHALLEN, B.SC., MBCHB, MRES, PH.D., LANCASHIRE TEACHING HOSPITALS, UNITED KINGDOM


DES PLAINES, IL — Providing financial incentives to forego testing significantly decreases patient preference for testing, even when accounting for test benefit and risk. That is the finding of a study published in the October 2019 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM).

The lead author of the study is Rahul Iyengar MD, a resident physician at Aurora St. Luke’s Medical Center, Milwaukee, WI.

The study explores the hypothesis that patient preferences for diagnostic testing will vary substantially when the patient is presented with different quantitative information about risk, benefit and cost.

This single center survey indicated that patient “acceptance rate” for computerized tomographic (CT) imaging of the head varied substantially, even if the assumed risk and benefit of the test were varied only slightly: either 0.1 or 1%. This work supports the hypothesis that discussing benefits and risks of low-value diagnostic testing via head CT scan with patients, even when absolute benefit or risk is very low, may impact patients’ decision-making and can be the scientific cornerstone of a shared decision-making model to reduce low value diagnostic testing

Further, providing financial incentives to forego testing significantly decreased patient preference for testing, even when accounting for test benefit and risk, suggesting that implementation of a cash incentive to forego unnecessary diagnostic testing may further prove to be a successful method to decrease healthcare costs for ED patients.

The authors suggest that further study of the impact of financial incentives on patient decision making across other clinical scenarios and in nonhypothetical patient situations is needed.

Commenting on the study is Jesse Pines, MD, the National Director of Clinical Innovation at US Acute Care Solutions and a professor of emergency Medicine at Drexel University. Dr. Pines works clinically in the emergency department at Allegheny General Hospital and Adventist Shady Grove Medical Center.
 

“This study was hypothetical in nature, but found financial incentives to patients to forego testing for head CT in low-risk scenarios lowered the likelihood they would choose to pursue testing, a preference that persisted even at different likelihoods of benefit and risk from the test. This demonstrates that patient preferences for ED care decisions may be influenced by financial considerations such as out-of-pocket costs — particularly in the case of using expensive tests like CT to find rare but important clinical findings. This work is important and deserves further study as increasingly patients are required to pay for care out-of-pocket in the United States.”

###

ABOUT ACADEMIC EMERGENCY MEDICINE

Academic Emergency Medicine, the monthly journal of Society for Academic Emergency Medicine, features the best in peer-reviewed, cutting-edge original research relevant to the practice and investigation of emergency care. The above study is published open access and can be downloaded by following the DOI link: https://doi.org/10.1111/acem.13823. Journalists wishing to interview the authors may contact Stacey Roseen at [email protected].

ABOUT THE SOCIETY FOR ACADEMIC EMERGENCY MEDICINE

SAEM is a 501(c)(3) not-for-profit organization dedicated to the improvement of care of the acutely ill and injured patient by leading the advancement of academic emergency medicine through education and research, advocacy, and professional development. To learn more, visit saem.org.

Media Contact
Stacey Roseen
[email protected]
708-606-7120

Related Journal Article

http://dx.doi.org/10.1111/acem.13823

Tags: Clinical TrialsCritical Care/Emergency MedicineDiagnosticsHealth Care Systems/ServicesHealth ProfessionalsMedicine/HealthTrauma/Injury
Share12Tweet8Share2ShareShareShare2

Related Posts

Gut γδ T17 Cells Drive Brain Inflammation via STING

Gut γδ T17 Cells Drive Brain Inflammation via STING

August 2, 2025
blank

Agent-Based Framework for Assessing Environmental Exposures

August 2, 2025

MARCO Drives Myeloid Suppressor Cell Differentiation, Immunity

August 2, 2025

Personalized ML Wearable Enhances Impaired Arm Function

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    36 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Gut γδ T17 Cells Drive Brain Inflammation via STING

Agent-Based Framework for Assessing Environmental Exposures

MARCO Drives Myeloid Suppressor Cell Differentiation, Immunity

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.